By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD


Company News
Gilead (GILD) Announces Third Quarter 2015 Dividend 7/29/2015 11:32:10 AM
Gilead (GILD) Announces Second Quarter 2015 Financial Results 7/29/2015 11:30:28 AM
Gilead (GILD) Announces Executive Promotions 7/28/2015 10:57:35 AM
Analysts Wait With Bated Breath for Gilead (GILD) Q2 Results, Possible Acquisition News 7/28/2015 6:08:06 AM
Report Shows Gilead (GILD) Creates $3.5 Million per Employee 7/24/2015 6:31:10 AM
Gilead (GILD) Announces Phase III Results From The First Study To Evaluate Switching From TDF-Based Regimens To A TAF-Based Regimen Containing Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide (E/C/F/TAF) 7/22/2015 10:41:25 AM
Gilead (GILD) To Release Second Quarter 2015 Financial Results On Tuesday, July 28, 2015 7/22/2015 10:38:43 AM
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall 7/9/2015 6:41:40 AM
Gilead (GILD) Bets $125 Million on Spurring Investigational HIV Drug to Market 7/7/2015 6:31:34 AM
Japan’s Ministry Of Health, Labour And Welfare Approves Gilead (GILD)’s Harvoni, The First Once-Daily Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C 7/6/2015 11:19:15 AM